Engineered NK cells with IL-21 show strong antitumor activity against glioblastoma

Natural killer (NK) cells engineered to express interleukin-21 (IL-21) demonstrated sustained antitumor activity against glioblastoma stem cell-like cells (GSCs) both in vitro and in vivo, according to new research from The University of Texas MD Anderson Cancer Center.

WebMD Ignite Unveils HealthHub Interactive to Support Health Plans’ Clinical Programs

What You Should Know: – WebMD Ignite, a full-service growth partner for organizations across the healthcare industry, today announced HealthHub Interactive for health plans, a

April 25, 2024

UnitedHealthcare, RUSH Health Form Medicare Advantage Relationship

What You Should Know: – UnitedHealthcare and RUSH Health announced a new relationship that will give UnitedHealthcare Medicare Advantage plan members network access to all

October 25, 2023

Immune dysregulation in long COVID patients uncovered in new study

Sstudy reveals significant immune changes in long COVID patients, including altered T cell responses and systemic inflammation, using advanced ‘omics’ and serological assays.

January 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.